|12 Months Ended|
Jul. 31, 2017
|Other Liabilities and Financial Instruments Subject to Mandatory Redemption [Abstract]|
|Other Liabilities Disclosure [Text Block]||
Note 9 - Other liabilities
At July 31 Other liabilities consist of:
The capital lease obligation and Installment loans are for machinery and equipment used in the Clinical Labs segment. Amortization of the assets recorded under the capital lease is included in depreciation expense. At July 31, 2017, the accumulated amortization on the capital lease was $517 and the imputed interest rate ranges from 4.25% to 9.5%.
Future minimum lease and loan payments are as follows:
The weighted average interest rate on our short term borrowings during fiscal 2017 and 2016 was 7.5% and 8.0%, respectively.
The entire disclosure for other liabilities.
Reference 1: http://www.xbrl.org/2003/role/presentationRef